Technical Specifications
| Drug Composition | Nintedanib |
|---|---|
| Variant / Strength | 150 mg |
| Dosage Form / Type | Capsules |
| Product Benefits | Treatment of Idiopathic pulmonary fibrosis & Non-small cell lung cancer |
| Packaging Type | Strip |
| Delivery Time | 7 - 15 Days, as per delivery location. |
| Country of Origin | Made in India |
| Export Destinations | USA, UK, UAE, Philippines, Thailand, Kenya, Nigeria, Germany, Canada, Mexico, and 65+ more countries |
| Export Route | Shipped via temperature-controlled international air courier with full customs documentation |
Nintedanib 150 mg Capsule is utilized for treating idiopathic pulmonary fibrosis and non-small cell lung cancer. Its mechanism involves targeting specific pathways crucial to the growth and progression of these conditions, effectively impeding or slowing down the proliferation of cancer cells.
For optimal benefits, Nintedanib 150 mg Capsule is recommended to be taken with food, consistently at the same time daily. The prescribed dosage and frequency are determined by your doctor, contingent upon the nature of the condition being treated. Precise adherence to your doctor's instructions is essential to avoid serious side effects, and discontinuation should only occur under your doctor's guidance.
A prevalent side effect of this medication is diarrhea. It is advisable to increase fluid intake and promptly inform your doctor if this side effect persists. Other common side effects encompass nausea, abdominal pain, vomiting, abnormal liver function tests, loss of appetite, headache, weight loss, and elevated blood pressure.
